
Philadelphia Pharmaceuticals Co. Upgraded to 'Hold' Amid Mixed Technical Indicators
2025-09-23 15:58:40Philadelphia Pharmaceuticals Co. has transitioned from a 'Not Rated' status to a 'Hold' designation by MarketsMOJO, reflecting a revised evaluation of its valuation and technical metrics. The company maintains a fair valuation and has shown stable financial performance, despite underperforming the broader market over the past year.
Read MoreNo announcement available
Corporate Actions
No corporate action available






